BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10919884)

  • 21. Treatment of liver metastases from uveal melanoma: a retrospective single-center analysis.
    Yang XY; Xie F; Tao R; Li AJ; Wu MC
    Hepatobiliary Pancreat Dis Int; 2013 Dec; 12(6):602-6. PubMed ID: 24322745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response of patients with metastatic uveal melanoma to combined treatment with fotemustine and sorafenib.
    Niederkorn A; Wackernagel W; Artl M; Schwantzer G; Aigner B; Richtig E
    Acta Ophthalmol; 2014 Dec; 92(8):e696-7. PubMed ID: 24774993
    [No Abstract]   [Full Text] [Related]  

  • 23. Progression of ocular melanoma metastasis to the liver: the 2012 Zimmerman lecture.
    Grossniklaus HE
    JAMA Ophthalmol; 2013 Apr; 131(4):462-9. PubMed ID: 23392528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Regional chemotherapy in treatment of patients with unresectable liver metastases of uveal melanoma].
    Moiseenko AV; Polikarpov AA; Tarazov PG; Korovina YV; Rozengauz EV; Shelkoplyas EN; Granov DA
    Vopr Onkol; 2016; 62(6):783-787. PubMed ID: 30695565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
    Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
    Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytogenetics and prognosis for uveal melanoma in Korean patients.
    Lee CS; Lee J; Choi JJ; Yang WI; Yoon JS; Lee SY; Lee SC
    Acta Ophthalmol; 2011 Jun; 89(4):e310-4. PubMed ID: 21310015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma.
    Kim IK; Lane AM; Gragoudas ES
    Arch Ophthalmol; 2010 Jul; 128(7):871-5. PubMed ID: 20625048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uveal Melanoma UK National Guidelines.
    Nathan P; Cohen V; Coupland S; Curtis K; Damato B; Evans J; Fenwick S; Kirkpatrick L; Li O; Marshall E; McGuirk K; Ottensmeier C; Pearce N; Salvi S; Stedman B; Szlosarek P; Turnbull N;
    Eur J Cancer; 2015 Nov; 51(16):2404-12. PubMed ID: 26278648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival from uveal melanoma in Western Australia 1981-2005.
    Chew AL; Spilsbury K; Isaacs TW
    Clin Exp Ophthalmol; 2015 Jul; 43(5):422-8. PubMed ID: 25556534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uveal melanoma: update and future directions.
    Rousseau AP
    Can J Ophthalmol; 2004 Jun; 39(4):335-42. PubMed ID: 15327097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obstacles to improving outcomes in the treatment of uveal melanoma.
    Tsai KK; Bollin KB; Patel SP
    Cancer; 2018 Jul; 124(13):2693-2703. PubMed ID: 29579316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Forty-year prognosis after plaque brachytherapy of uveal melanoma.
    Stålhammar G
    Sci Rep; 2020 Jul; 10(1):11297. PubMed ID: 32647177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma.
    Bol KF; van den Bosch T; Schreibelt G; Mensink HW; Keunen JE; Kiliç E; Japing WJ; Geul KW; Westdorp H; Boudewijns S; Croockewit SA; van Rossum MM; de Goede AL; Naus NC; van der Graaf WT; Gerritsen WR; de Klein A; Punt CJ; Figdor CG; Cohen VM; Paridaens D; de Vries IJ
    Ophthalmology; 2016 Oct; 123(10):2265-7. PubMed ID: 27476772
    [No Abstract]   [Full Text] [Related]  

  • 34. Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients.
    Klingenstein A; Haug AR; Zech CJ; Schaller UC
    Cardiovasc Intervent Radiol; 2013 Feb; 36(1):158-65. PubMed ID: 22526099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and toxicity of transarterial chemoembolization therapy using cisplatin and gelatin sponge in patients with liver metastases from uveal melanoma in an Asian population.
    Shibayama Y; Namikawa K; Sone M; Takahashi A; Tsutsumida A; Sugawara S; Arai Y; Aihara Y; Suzuki S; Nakayama J; Imafuku S; Yamazaki N
    Int J Clin Oncol; 2017 Jun; 22(3):577-584. PubMed ID: 28144882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repetitive chemoembolization of hypovascular liver metastases from the most common primary sites.
    Farshid P; Darvishi A; Naguib N; Bazrafshan B; Paul J; Mbalisike E; Vogl TJ
    Future Oncol; 2013 Mar; 9(3):419-26. PubMed ID: 23469977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on Metastatic Uveal Melanoma: Progress and Challenges.
    Spagnolo F; Picasso V; Spano L; Tanda E; Venzano C; Queirolo P
    BioDrugs; 2016 Jun; 30(3):161-72. PubMed ID: 27000042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for uveal melanoma metastasis. Literature review.
    Missotten GS; Keunen JE
    Bull Soc Belge Ophtalmol; 2004; (294):13-22. PubMed ID: 15682915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes.
    Shields CL; Furuta M; Thangappan A; Nagori S; Mashayekhi A; Lally DR; Kelly CC; Rudich DS; Nagori AV; Wakade OA; Mehta S; Forte L; Long A; Dellacava EF; Kaplan B; Shields JA
    Arch Ophthalmol; 2009 Aug; 127(8):989-98. PubMed ID: 19667335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival.
    Augsburger JJ; Corrêa ZM; Trichopoulos N
    Am J Ophthalmol; 2011 Jul; 152(1):5-9.e1. PubMed ID: 21601175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.